Patents by Inventor Bernhard PAETZOLD

Bernhard PAETZOLD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11541081
    Abstract: Aspects of the invention relate to compositions comprising two or more live bacterial strains for topical administration to the skin, wherein the two or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: January 3, 2023
    Assignee: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20210187043
    Abstract: Aspects of the invention relate to compositions comprising two or more live bacterial strains for topical administration to the skin, wherein the two or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: October 19, 2017
    Publication date: June 24, 2021
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20200392452
    Abstract: Aspects of the invention relate to compositions comprising one or more live bacterial strains for topical administration to the skin, wherein the one or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 17, 2020
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Patent number: 10774305
    Abstract: Aspects of the invention relate to compositions comprising one or more live bacterial strains for topical administration to the skin, wherein the one or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: September 15, 2020
    Assignee: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Patent number: 10745450
    Abstract: The invention provides a series of peptide signals which, when linked to a polypeptide of interest (POI), ensure that said polypeptide is secreted in high yields by a host cell such as Mycoplasma pneumoniae. The invention also provides fusion proteins tagged with said peptide signals, the nucleic acid sequences coding for them, host cells comprising said tagged fusion proteins and a variety of uses of the fusion proteins and the host cells.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: August 18, 2020
    Assignees: FUNDACIÓ CENTRE DE REGULACIÓ GENÓMICA (CRG), INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS
    Inventors: Bernhard Paetzold, Maria Lluch Senar, Luis Serrano Pubul
  • Publication number: 20190314428
    Abstract: Aspects of the invention relate to compositions comprising two or more live bacterial strains for topical administration to the skin, wherein the two or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: October 19, 2017
    Publication date: October 17, 2019
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20180142202
    Abstract: Aspects of the invention relate to compositions comprising one or more live bacterial strains for topical administration to the skin, wherein the one or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: April 20, 2016
    Publication date: May 24, 2018
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20180037613
    Abstract: The invention provides a series of peptide signals which, when linked to a polypeptide of interest (POI), ensure that said polypeptide is secreted in high yields by a host cell such as Mycoplasma pneumoniae. The invention also provides fusion proteins tagged with said peptide signals, the nucleic acid sequences coding for them, host cells comprising said tagged fusion proteins and a variety of uses of the fusion proteins and the host cells.
    Type: Application
    Filed: February 26, 2016
    Publication date: February 8, 2018
    Inventors: Bernhard PAETZOLD, Maria LLUCH SENAR, Luis SERRANO PUBUL